Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.
Conclusions: From our data, FLCs appear to be a sensitive marker of B cell activation in MG. Further investigations are necessary to exploit their potential as reliable biomarkers of disease activity.
PMID: 29765992 [PubMed - in process]
Source: Journal of Immunology Research - Category: Allergy & Immunology Tags: J Immunol Res Source Type: research
More News: Allergy & Immunology | Arthritis | Autoimmune Disease | Brain | Lupus | Myasthenia Gravis | Neurology | Rheumatoid Arthritis | Rheumatology | Rituxan | Statistics